Article Details

Investors urge Smith+Nephew to consider break-up over orthopedics performance

Retrieved on: 2024-11-15 18:30:51

Tags for this article:

Click the tags to see associated articles and topics

Investors urge Smith+Nephew to consider break-up over orthopedics performance. View article details on hiswai:

Excerpt

Smith+Nephew's stock (NYSE:SNN) grew 1.5% in 2023, according to a MassDevice analysis of the largest medtech companies' stock performances.

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up